The Crux of Medtech

In this episode of the Crux of Neuro, Renee Ryan, co-founder and CEO of PinPrint and former CEO of Cala Health. Renee traces her path from Wall Street healthcare banker to one of medtech’s most prolific investors and operators. She explains why, in neurotech today, getting reimbursed is often harder than getting cleared and how data became the whole story.

Key Topics

In this episode, Jordan is joined by Ahmed Elmouelhi, President & CEO of TRiCares, the company behind Topaz, a purpose-built transcatheter tricuspid valve replacement system now in head-to-head pivotal trial against Edwards EVOQUE in the US.

Ahmed brings over 20 years of structural heart experience, including nearly a decade building TAVR and LAA therap...

In this episode of the Crux of Neuro, Liz Moyles is joined by Hubert Martens, physicist-turned-entrepreneur, co-founder of Sapiens Steering Brain Stimulation (acquired by Medtronic for ~$200M), and now CEO of Salvia BioElectronics. Hubert shares how a career that started with double-layer DVD technology at Philips led him to building a patient-centred neuromodulation implant ...

In this episode of the Crux of MedTech, Henry Norton is joined by Tatiana Lobanov-Rostovsky, Investor at Oxford Science Enterprises, the independent, billion-pound investment company built in partnership with the University of Oxford. With a background in neuroscience, Healthcare M&A at Rothschild & Co, and hands-on experience inside a biotech startup, Tatiana brings ...

In this episode, your host, Jordan Burgin, is joined by Vlastimil Hrabal, CEO and Co-Founder of Kardi AI, to unpack why a 24-hour Holter monitor the hospital gold standard misses most dangerous arrhythmias, and how long-term, AI-evaluated ECG monitoring is changing detection, prevention, and the economics of cardiac care.

Key Topics

Why long-term ECG monitoring ou...